Intellectual Property

• 

  Venner Shipley is a leading firm of European patent and trade mark attorneys, representing a broad range of clients including major international corporations, SMEs, universities and spin-out companies.

  The firm has over 40 attorneys, who collectively provide a full range of intellectual property services covering patents, trade marks, designs & copyright, domain names and all other aspects of IP, in all areas of science and technology.

  Our services extend beyond rights protection, to involvement in enforcement and licensing activities. We aim to provide the highest standards of service, while recognising that responsiveness and reasonable fees are just as important as technical and legal expertise.

  We will be hosting a webinar on Wednesday 27th October entitled Creating strong patents in Europe: 'How much data is needed & when by?' For further information and to register, click here 

• →News

  The Patentability of Stem Cells

  Written by Kate McNamara and guest contributor Maryanne Trevisan of Wolf Greenfields & Sacks, P.C., this article provides an insight into the developments of patenting stem cell technology in both the UK and the US.

  Click here to read the full article:
  
  http://www.vennershipley.co.uk/show-news-id-182.html

  EPO Pronounces Verdict on Patenting Stem Cell Technology

  Kate McNamara provides an update from the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) concerning the patentability of stem cells.

  Click here to read the full article:

  http://www.vennershipley.co.uk/show-news-id-173.html

  Pharmaceutical Implications following the EPO decision

  Allie Elend discusses the complications surrounding patent filings in the pharmaceutical sector following the recent decision made by the EPO.

  Click here to read the full article:

  http://www.vennershipley.co.uk/show-news-id-171&p=6.html

  The Amazon Gift-Giving European Patent

  In this article Diana Pisani gives her thoughts on computer-implemented inventions which include Amazon’s US patent for its “one-click” technology.

  To read the full article click here:

  http://www.vennershipley.co.uk/show-news-id-237&p=1.html

  Sugababes : So who owns a band’s name?

  Kate Széll and Julia McFarlane give an insight into the ongoing dispute over ownership of the Sugababes band name and explain the importance of registering your trademark within the music industry.
  
  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-238&p=1.html

  The European Court of Justice Refers Patenting Stem Cell Technology

  Kate McNamara provides an update on the ongoing issue surrounding the patentability of stem cells in Europe and explains the reasons behind the Enlarged Board of Appeal (EBA) of the European Patent Office decision G2/06.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-239&p=1.html

  Raising the Bar: The European Patent office initiative

  Eimear Ward looks into the “Raising the Bar” initiative of the European Patent Office (EPO) and examines the impact this initiative has on the prosecution of patents before the EPO, and what effect, if any, they have on patent quality.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-241&p=1.html

  EPO Pronounces Verdict on Patenting Computer-Implemented Inventions

  Jonathan Hewett provides an update from The Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) concerning the decision of G3/08 on the patentability of computer-implemented inventions.

  To read the full article click here:

  http://www.vennershipley.co.uk/show-news-id-240&p=1.html

  The Community Patent: A Political Breakthrough

  Olivia Johansson discusses the changes surrounding the Community Patent, as it was formerly known, and how it has recently been transformed into the EU Patent.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-242&p=1.html

  The patentability of Proteins

  Tanya Heare examines the issues surrounding the patentability of proteins, the ‘industrial application’ requirements and how this affects the wider field of pharmaceuticals.

  To read the full article click here:

  http://www.vennershipley.co.uk/show-news-id-243&p=1.html

  The European Patent Office Lingo

  In this article Karen Ng provides important information regarding the official language of EPO proceedings.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-245&p=1.html

  European General Court Issues first Design Decision

  In this article Alexander Brown discusses The European General Court’s recent first ruling on a Registered Community Design (RCD).

  To read the full article click here:

  http://www.vennershipley.co.uk/show-news-id-246&p=1.html

  Community Trade Marks: The Process and Benefits 

  Kate Széll explains the process of community trade mark registration (CTM) and clarifies the importance of maintaining the registered protection.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-247&p=2.html

  The EPO Issues Decisions on Medical Methods in Europe

  Stephen Johnson summarises on the decisions made by the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) regarding the patentability of methods of treatment, surgery and diagnosis G 1/07 and G 2/08. In this article Stephen also discusses content of these decisions and the implications in respect of European patents and patent applications.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-248&p=2.html

  IP Actions: To Bid or Not To Bid?

  Michelle Jamieson summarises on the auction process for IP assets and looks at the recent trends in this area as well as commenting on the successes and failings of the auction process.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-249&p=2.html

  Double Patenting: The Facts

  David Paton discusses the issue of double patenting under the European Patent Convention (EPC), which has re-emerged due to the recent decisions made by the Technical Board of Appeal of the European Patent Office (EPO).

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-250&p=2.html

  Security Provisions: The Restrictions

  In this article Alex Bruce examines the issues surrounding the security provisions that restrict filings of patent applications for inventions.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-251&p=2.html

  New Guidelines Encourage the EPO to get tough

  Oliver Anderson provides an insight into the recent changes to the guidelines for examination in the European Patent Office (EPO) and how these amendments may be subjective of the criteria for patentability for the skilled worker.

  To read the full article click here:
  
  http://www.vennershipley.co.uk/show-news-id-252&p=2.html

  The Patentability of Stem Cells – A European Perspective

  Kate McNamara summaries on the decision made by the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) regarding the patentability of stem cells (G2/06). In this article Kate also discusses the recent German Supreme Court decision to refer some questions about the use of stem cells to the European Court of Justice.

  Click here to read the full article:
  
  http://www.vennershipley.co.uk/show-news-id-235.html

• →How we can help

  Biotechnology is one of the firm’s core disciplines and our attorneys are experienced in  dealing with all aspects of IP protection, having worked with numerous biotech companies based in the UK and overseas.

  Our team has substantial expertise in relation to inventions in the fields of biotechnology, chemistry and pharmaceuticals. We specialise in diverse fields, including diagnostics and therapeutics, genomics & proteomics, cancer therapeutics, immuno-therapeutics, viral vectors & gene delivery, drug delivery, formulation chemistry, chiral chemistry, protein and peptide chemistry, synthetic organic chemistry, nanotechnology, catalytic and process chemistry, cell culturing technology and equipment, medical devices, and polymer chemistry.

  Our Chemical & Life Sciences team has extensive experience of drafting and prosecuting patent applications at the UK Intellectual Property Office and the European Patent Office, and overseas through a network of associates. In addition to assisting our clients to obtain patent protection in the field of biotechnology, we also have vast experience of providing advice on potential infringement.

  We also prepare freedom-to-operate and due diligence reports, especially for use in connection with company acquisitions and raising funding, and we also have experience of attending meetings with potential investors to advise on the value of our clients' patent portfolios.
  

• →Our offer to LBIC clients

  1) Free patentability assessment – we will not charge for reviewing an Invention Disclosure, or for providing an initial brief patentability opinion
  2) Transparency of costs, and a significant discount on our hourly rates
  3) Attorney experience - we will ensure that jobs for you are completed by an attorney at the correct seniority
  4) Free In-house IP clinics tutorials, seminars and IP training sessions to LBIC clients
  5) Regular contact – we will keep you informed of important developments in IP law via our regular newsletter.
  

• →Contact Venner Shipley

  Please include your email address and telephone number.